课题基金 / 基金详情

Cure Sickle Cell

Cure Sickle Cell
治愈镰状细胞
批准号:
10270068
负责人:
MARY EAPEN
金额:
$987.22万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-28 至 2023-09-27

项目摘要

项目成果

MARY EAPEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Cure Sickle Cell (CureSC) Initiative was created in 2017 by the National Heart, Lung, and Blood Institute (NIH/NHLBI) to: • Actively engage the sickle cell disease community of patients, family members, caregivers and advocates to work together on a path to the cure • Utilize the emergence of safe reliable genetic therapies that broadens opportunities to improve the lives of individuals with sickle cell disease • Use public-private partnership and collaboration among government agencies, biopharmaceutical companies and researchers to result in more rapid advancement of new and innovative treatments and technologies
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Medical College of Wisconsin Physician Scientist Immersion Program
  • 批准号:
    10591714
  • 项目类别:
  • 资助金额:
    $19.51万
  • 财政年份:
    2023
  • 负责人:
    MARY EAPEN
  • 依托单位:
Cure Sickle Cell
  • 批准号:
    10912972
  • 项目类别:
  • 资助金额:
    $1355.78万
  • 财政年份:
    2018
  • 负责人:
    MARY EAPEN
  • 依托单位:
海外基金